Skip to Main Content

Paper Details

Molecular Characterization of Residual Bladder Cancer after Neoadjuvant Pembrolizumab.
Eur Urol
13
2021
Author NameAffiliation
Alberto BrigantiVita-Salute San Raffaele University, IRCCS San Raffaele Hospital and Scientific Institute
Elai DavicioniDecipher Biosciences Inc.
Jonathan L WrightUniversity of Washington
  • 1 - 3

Datasets

Release 1.2